CS Paper Radar

A Multimodal Foundation Model for Longitudinal Patient Representation and Scalable Insight Generation in Oncology

Eugene Vorontsov, Yi Kan Wang, Alican Bozkurt, Adam Casson, Ludmila Tydlitatova, Michal Zelechowski, Ezra E. W. Cohen, Jyoti D. Patel, Max Banaszak, Caitlin McWilliams, Shane Colley, Kate Sasser, Ryan Fukushima, Eric Lefkofsky, Razik Yousfi, Siqi Liu

cs.LG ·submitted 2026-08-25 15:17 UTC · v1

Abstract

Precision oncology necessitates a longitudinal model of patient state that captures cancer evolution and treatment over time, integrating multimodal observations. We introduce the oFM, a foundation model developed on a real-world oncology cohort of 1.67 million cancer patients that integrates clinical trajectories with DNA, RNA, and H&E pathology. Patient-level partitions were reserved for training, validation, and testing, with over one million patients used for training. The oFM encodes daily clinical and molecular episodes and, along with pathology images, integrates them over time to produce a patient state embedding. We evaluate frozen oFM embeddings against expert-curated clinical and molecular baseline features. In prognostic benchmarks, the oFM improved AUC for treatment response, progression-free survival, and overall survival (0.774 vs. 0.563 for overall survival). Across 11 comparative-treatment cohorts, the oFM embeddings achieved a three-fold higher pooled and scale-normalized treatment-benefit AUTOC than baseline features with improved benefit ranking in 9 of 11 cohorts, and provided stronger prognostic discrimination within both treatment arms. We also evaluated a mechanism discovery framework that interprets downstream models built on oFM embeddings by linking their predicted outcomes to clinically and biologically grounded mechanisms through an evidence-grounded temporal graph, enabling evaluation in clinical and drug-development applications.

Closest papers

Nearest neighbours by meaning across the whole index.

MIST: Multimodal Survival Prediction with Genomic-Guided Histology Attention

cs.AI cs.CV ·2026-09-18 ·Muhammet Sami Yavuz, Sabri Mustafa Kahya, Richard R. Chen, Jana Lipkova, Benedikt Wiestler
publishedcode/data similarity 0.71
Abstract · Accepted at the COMPAYL 2026 Workshop on Computational Pathology and Multimodal Data at MICCAI 2026. 11 pages, 2 figures, 4 tables

Multimodal survival models can combine complementary prognostic information from whole-slide images and genomic profiles, but effective fusion remains challenging amid external cohort shift and computational complexity. To address these challenges, we propose MIST, multimodal survival prediction with genomic-guided histology attention. MIST represents genomic features as tokens and allows them to query compact foundation-model-derived histology context tokens before survival prediction. This design enriches molecular information with histology context rather than merging separately encoded modalities only at the final stage. Training combines discrete-time survival prediction with genomic feature masking, WSI dropout, and paired WSI-genomics contrastive alignment. Across four external evaluations in colon, renal, lung, and glioblastoma cohorts, MIST improves external C-index over standard fusion baselines in the primary comparisons. These results support genomic-guided histology attention as a compact and effective strategy for multimodal oncology outcome prediction. Our code is available at https://github.com/samiyavuuz/MIST .

0.34

CACSurv: Concordance-Aligned Comparative Learning with Large Language Models for Cancer Survival Prediction

cs.AI ·2026-08-17 ·Tianqi Xiang, Qixiang Zhang, Xinpeng Ding, Yi Li, Xiaomeng Li
benchmarkcode/data similarity 0.70
Abstract

Cancer survival prediction supports treatment planning, risk stratification, and follow-up management. Existing methods use structured clinical variables, whole-slide images, genomic profiles, or multimodal inputs, while patient reports remain underexplored. We study report-centric survival prediction using reports that organize pathological, clinical, and molecular evidence. Large language models (LLMs) can reason over such reports, but case-wise time regression introduces two mismatches. First, a formulation mismatch arises because survival evaluation depends on ordering comparable patients, whereas independent time predictions do not enforce ranking consistency. Second, a supervision mismatch arises because a censored patient's observed time indicates survival beyond that point and cannot serve as an exact regression target, although it still implies orderings relative to patients who died earlier. To address these mismatches, we propose CACSurv, a Concordance-Aligned Comparative framework for report-centric survival prediction. CACSurv reformulates survival modeling as mini-cohort comparative reasoning, where an LLM predicts relative prognostic orderings. We introduce concordance-aligned rewards derived from comparable relations under right censoring, enabling censored outcomes to provide ranking supervision without exact event-time targets. At inference, Monte Carlo Reference Aggregation compares each patient with sampled references and aggregates positions into a cohort-level ranking. We establish TCGA-SurvReport, a benchmark covering six TCGA cancer cohorts. CACSurv achieves the highest C-index on all six cohorts and an average C-index of 0.722, outperforming the strongest published survival model by 6.5 percentage points and the strongest LLM time-regression baseline by 4.2 percentage points. Our code, models, and dataset will be available at https://github.com/xmed-lab/CACSurv.

0.52

MultiSigBERT: Beyond Survival Analysis through Multimodal and Sequential Modeling in Oncology

cs.LG ·2026-08-17 ·Paul Minchella, Stéphane Chrétien, Guillaume Metzler, Loïc Verlingue, Rémi Vaucher
published similarity 0.70
Abstract · Accepted at ECML PKDD 2026, Applied Data Science Track

Machine learning has become an essential component of modern healthcare, where the integration of heterogeneous data sources offers unprecedented opportunities to improve clinical decision-making. Electronic Health Records (EHR) contain complementary information -- including narrative clinical reports, numerical measurements, and structured variables -- yet most survival models remain limited to a single modality or fail to exploit the temporal nature of patient trajectories. We propose MultiSigBERT, a unified framework for multimodal sequential survival modeling in oncology based on path signature representations. Here, narrative medical reports (free-text) are converted into sentence embeddings by extracting and averaging contextual word embeddings. These representations are then compressed via modality-specific PCA and concatenated with structured covariates to form joint temporal trajectories which are then encoded using the Signature transform, a tool from Rough Paths theory that efficiently captures higher-order temporal interactions across modalities without supervision needed. The computed Signature features are finally incorporated as high dimensional features into a LASSO-regularized Cox model to estimate individualized risk scores. The performance of our novel MultiSigBERT pipeline is illustrated on the analysis of a real-world oncology cohort from the Léon Bérard Center, comprising over 120,000 medical reports and structured records from more than 2,500 patients. The model achieves a concordance index of 0.743 (sd 0.029) on an independent test set, demonstrating the benefit of jointly modeling multimodal temporal dynamics together with patient-level geometric structure for survival prediction.

0.39

Real-World Multi-Modal and Longitudinal Lung Cancer Dataset

eess.IV cs.CV ·2026-09-04 ·Rita Cordeiro Mendes, Maria Rita Fonseca Verdelho, Carlos Santiago, Catarina Barata
publishedbenchmarkcode/data similarity 0.70
Abstract · Accepted at ECCV 2026 Workshop on Data Curation & Augmentation in Medical Imaging

Multi-modal learning has demonstrated strong potential in medical applications by integrating heterogeneous data sources such as medical imaging, clinical records, and genomics to improve predictive performance and support clinical decision-making. However, advances in this area are often constrained by two key challenges: the limited availability of well-curated, ready-to-use datasets that accurately reflect real-world conditions, where medical data are frequently collected inconsistently and are often incomplete; and the inherent difficulty of integrating heterogeneous data modalities. In this work, we introduce a newly curated multi-center, multi-modal, and longitudinal dataset designed to support the evaluation of a wide range of learning pipelines under realistic conditions. The dataset comprises a total of 1,365 lung cancer patients and has three imaging modalities (whole-slide images, CT scans, and PET scans), structured clinical data, transcriptomic, and longitudinal follow-up and treatment information. For each imaging modality the dataset contains more than one instance. Moreover, the dataset exhibits substantial and non-uniform missingness across modalities, making it well-suited for studying robust multi-modal fusion strategies. We further provide both uni-modal and multi-modal benchmarks on the task of 12-month overall survival prediction, disease-specific survival, as well as longitudinal benchmark of hazard prediction under severe missing data. Our results show that, despite high levels of missingness, integrating complementary modalities consistently improves predictive performance over uni-modal approaches, highlighting the value of multi-modal fusion in realistic clinical settings. The dataset and benchmark code are available at https://github.com/ritacmendes/MMIST-LUNG.

0.33

Anchor-driven Multi-modal Multi-scale Expert Selection for Survival Prediction

cs.CV ·2026-10-06 ·Tao Zhou, Ying Hu, Huazhu Fu, Yi Zhou, Xiao-Jun Wu +1 more
top venuecode/data similarity 0.68
Abstract · 15 pages, 6 figures, 7 tables

The integrative analysis of histopathological Whole-Slide Images (WSIs) and transcriptomic profiles holds significant promise for cancer survival prediction. However, existing methods typically project multi-modal features directly into a shared latent space without explicit alignment, leading to the entanglement of mismatched morphological cues and molecular signals. Furthermore, current fusion strategies often treat the extreme spatial heterogeneity of WSIs uniformly, lacking mechanisms to adaptively prioritize clinically relevant tissue scales for individual patients. To address these limitations, we propose an Anchor-driven Multi-modal Multi-scale Expert Selection (AM$^2$ES) framework for survival prediction. Specifically, we present an Anchor-driven Multi-modal Fusion (AMF) module, which introduces learnable semantic anchors as cross-modal mediators to bridge the semantic gap by enforcing a structurally regularized alignment between transcriptomic features and multi-scale pathology representations. Built upon this aligned semantic space, we further design a Hierarchical Mixture-of-Experts (H-MoE) selection module to decouple the hierarchical prognostic selection process. Mimicking the pathologist's diagnostic workflow, H-MoE performs (i) Intra-scale Expert Filtering to discriminatively identify salient tumor regions within each magnification, and (ii) Inter-scale Hierarchy Routing to dynamically weight and select the most informative resolution levels. Extensive experiments on multiple TCGA cancer cohorts demonstrate that our AM$^2$ES achieves state-of-the-art performance while offering fine-grained interpretability by visualizing how specific molecular pathways drive the expert routing decisions across tissue scales. The code will be released at https://github.com/taozh2017/AM2ES.

0.47

CRUX: Clinical-Text Anchoring for Cross-Institutional CT-Pathology Fusion in Non-Small Cell Lung Cancer Survival Prediction

eess.IV ·2026-10-15 ·Kyungwon Kim, Dosik Hwang
similarity 0.68
Abstract · 15 pages, 5 figures, 6 tables. Preprint. Extended version of a MICCAI 2024 paper (Kim et al., 2024)

Accurate prognosis in non-small cell lung cancer (NSCLC) benefits from integrating computed tomography (CT) and histopathological whole-slide images (WSIs), which capture complementary macroscopic and microscopic disease characteristics. Fusing these modalities is difficult: their features come from different pretrained foundation-model encoders and lack spatial correspondence, and both are sensitive to institution-specific acquisition and staining, causing multimodal models to overfit site-specific artifacts and generalize poorly. We present CRUX (CRoss-modal Unification via teXt anchoring), a fusion framework that uses clinical text---encoded by a biomedical language model---as an institution-invariant semantic anchor. Because clinical variables follow standardized classification systems, their embeddings occupy a representation space that is consistent across institutions, providing a stable reference frame for aligning heterogeneous imaging features. CRUX introduces a text-mediated cross-modal bridge in which CT- and pathology-derived text-query summaries exchange information within a compact text semantic space through a learnable hub token, avoiding direct image-space cross-attention that would propagate domain-specific artifacts. We evaluate on 2,157 NSCLC patients from five hospitals, holding out one hospital (N=446) entirely for external validation. CRUX attains an external concordance index (C-index) of 0.761, the highest among all unimodal, bimodal, and trimodal configurations. Notably, direct CT-WSI fusion degrades under distribution shift, whereas text anchoring restores and improves cross-institutional generalization. These results indicate that language-model-encoded clinical text is an effective structured prior for robust, generalizable multimodal cancer prognosis.

0.12

Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies

cs.AI ·2026-10-02 ·Jungkyu Park, Dhruva Biswas, Joseph Cappadona, Cerise Tang, Ken G. Zeng +20 more
similarity 0.68
Abstract

Scarcity of labeled data limits development of deep learning biomarkers in oncology. We develop a two-stage AI model predicting pathological complete response (pCR) to neoadjuvant therapy in breast cancer. The first stage learns the transcriptome from histopathology using 8,742 patients across 32 cancer types, corroborated by pathologist review and spatial agreement with measured expression. This simplifies the second stage to predicting pCR from inferred expression and clinical variables. Developed using 1,080 patients (five cohorts) and evaluated in 1,412 patients (nine cohorts), the model achieves a pooled AUROC of 0.79 (95% CI, 0.73-0.85), discriminating responders within molecular subtypes. It outperforms histopathological biomarkers, remaining stable across intratumoral sampling and with minimal biopsy tissue. Ablations show transcriptome-wide inference improves discrimination over clinical variables alone or one-stage pathology models, and robustness by avoiding genomic assays' gene selection constraints. These results indicate that biologically informed compression may generalize to data-sparse applications in precision oncology.

0.06

Multi-Modal Tumor Survival Prediction via Graph-Guided Mixture of Experts

cs.LG cs.MA ·2026-09-12 ·H Mathavan, H Liu
similarity 0.68
Abstract

Large Language Models (LLMs) have displayed impressive capabilities in handling tasks that require few demonstration examples, making them effective few-shot learners. Despite their potential, LLMs face challenges when it comes to addressing complex real-world tasks that involve multiple modalities or reasoning steps. For example, predicting cancer patients' survival period based on clinical data, cell slides, and genomics poses significant logistical complexities. Although several approaches have been proposed to tackle these challenges, they often fall short in achieving promising performance due to their inability to consider all modalities simultaneously or account for missing modalities, variations in modalities, and the integration of multi-modal data, ultimately compromising their effectiveness. This thesis proposes a novel approach for multi-modal tumor survival prediction to address these limitations. Taking inspiration from recent advancements in LLMs, particularly Mixture of Experts (MoE)-based models, a graph-guided MoE framework is introduced. This framework utilizes a graph structure to manage the predictions effectively and combines multiple models to enhance predictive power. Rather than training a single foundation model for end-to-end survival prediction, the approach leverages a MOE-guided ensemble to manage model callings as tools automatically. By leveraging the strengths of existing models and guiding them through a MOE framework, the aim is to achieve better performance and more accurate predictions in complex real-world tasks. Experiments and analysis on the TCGA-LUAD dataset show improved performance over the individual modal and vanilla ensemble models.

0.07